New On Robinhood

Nurix Therapeutics

$43.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (+0.56%) As of 8:52 PM UTC today

Why Robinhood?

You can buy or sell NRIX and other stocks, options, and ETFs commission-free!

About NRIX

Nurix Therapeutics, Inc. Common stock, also called Nurix Therapeutics, is a biopharmaceutical company. It focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA. The listed name for NRIX is Nurix Therapeutics, Inc. Common stock.

CEO
Arthur T. Sands
Employees
93
Headquarters
San Francisco, California
Founded
2009
Market Cap
1.53B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
411.06K
High Today
$45.00
Low Today
$42.67
Open Price
$42.67
Volume
109.76K
52 Week High
$52.38
52 Week Low
$15.21

Collections

NRIX Earnings

-$0.59
-$0.39
-$0.20
$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Jan 27, After Hours

You May Also Like

AZAJ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure